Prevalence and management of hypertension in Turner syndrome: data from the International Turner Syndrome (I-TS) registry.
Mathara Diddhenipothage SAD. et al, (2025), Endocr Connect, 14
Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
Moolla A. et al, (2025), JHEP Reports, 101363 - 101363
New Approaches to the Treatment of Hypercortisolism.
Pofi R. et al, (2025), Annu Rev Med, 76, 431 - 445
Lessons to learn from the 2024 NICE guideline on adrenal insufficiency.
Dong J. and Tomlinson JW., (2024), Lancet Diabetes Endocrinol
Prospective cohort for early detection of liver cancer (Pearl): a study protocol.
Khanna K. et al, (2024), BMJ Open, 14
Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans
Westcott F. et al, (2024), European Journal of Endocrinology (EJE)
Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain
Hodson D. et al, (2024)
Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD.
Colosimo S. et al, (2024), Diabetes Res Clin Pract
Are we putting patients on steroid treatment at risk under anaesthesia?
Tomlinson JW., (2024), Anaesthesia
Development of diagnostic algorithm for Cushing's syndrome: a tertiary centre experience.
Efthymiadis A. et al, (2024), J Endocrinol Invest
Service evaluation suggests variation in clinical care provision in adults with congenital adrenal hyperplasia in the UK and Ireland.
Doyle LM. et al, (2024), Clin Endocrinol (Oxf)
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice.
Brennan PN. et al, (2024), Lancet Gastroenterol Hepatol
Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction
Tomlinson JW., (2024), Diabetes, Obesity and Metabolism
Alterations in plasma protein N-glycosylation after caloric restriction and bariatric surgery.
Štambuk T. et al, (2024), Surg Obes Relat Dis
Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study.
Miller H. et al, (2024), BMJ Open, 14
Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis.
Koutoukidis DA. et al, (2024), Gut Microbes, 16
A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: A pilot study.
Colosimo S. et al, (2023), Nutr Metab Cardiovasc Dis